Considerations for Incorporating New ABSSSI and CABP Treatment Options into Clinical Practice (Part 1 of 3)
John Esterly is interviewed by Scott Bergman and discusses considerations for incorporating new acute bacterial skin and skin structure infections (ABSSSI) and community-acquired bacterial pneumonia (CABP) treatment options into the pharmacist’s practice. The interview was conducted in December 2013 during the ASHP Midyear Clinical Meeting. Faculty: John Esterly, Pharm.D., BCPS (AQ-ID), Activity Chair Assistant Professor, Pharmacy Practice Chicago State University College of Pharmacy Infectious Diseases Pharmacist Northwestern Memorial Hospital Chicago, Illinois Scott Bergman, Pharm.D., BCPS (AQ-ID) Associate Professor Southern Illinois University Edwardsville Clinical Pharmacy Specialist and PGY2 Infectious Diseases Residency Program Director St. John’s Hospital Springfield, Illinois C.E. Credits: This activity is not eligible for continuing education credits.